| MIR148B |
|
microRNA 148b
|
|
|
0.592 |
0.692 |
| MIR425 |
|
microRNA 425
|
|
|
0.581 |
0.654 |
| HPT |
|
hypoparathyroidism
|
|
|
0.593 |
0.692 |
| MIR374B |
|
microRNA 374b
|
|
|
0.621 |
0.500 |
| ESAT |
|
esterase activator
|
|
|
0.716 |
0.308 |
| HBHR |
|
alpha-thalassemia/mental retardation syndrome, type 1
|
|
|
0.711 |
0.577 |
| DEFA1A3 |
|
defensin alpha 1 and alpha 3, variable copy number locus
|
|
|
0.751 |
0.423 |
| HLA-DPB2 |
|
major histocompatibility complex, class II, DP beta 2 (pseudogene)
|
|
|
0.743 |
0.500 |
| MIR365B |
|
microRNA 365b
|
|
|
0.769 |
0.308 |
| HORMAD2-AS1 |
|
HORMAD2 and MTMR3 antisense RNA 1
|
|
|
0.839 |
0.308 |
| IGAN2 |
|
IgA nephropathy, susceptibility to, 2
|
|
|
1.000 |
0.115 |
| MIR555 |
|
microRNA 555
|
|
|
1.000 |
0.115 |
| HELT |
A6NFD8
|
helt bHLH transcription factor
|
|
1.0E-03 |
0.890 |
0.115 |
| TLR4 |
O00206
|
toll like receptor 4
|
|
4.6E-09 |
0.321 |
0.962 |
| PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |
| ELL2 |
O00472
|
elongation factor for RNA polymerase II 2
|
Cell-cell junction
|
1.00 |
0.722 |
0.269 |
| CCL21 |
O00585
|
C-C motif chemokine ligand 21
|
Signaling
|
3.6E-02 |
0.502 |
0.769 |
| MAN2B1 |
O00754
|
mannosidase alpha class 2B member 1
|
|
4.8E-22 |
0.674 |
0.462 |
| APOL1 |
O14791
|
apolipoprotein L1
|
Transporter
|
5.1E-06 |
0.547 |
0.615 |
| TNFRSF13B |
O14836
|
TNF receptor superfamily member 13B
|
|
2.1E-15 |
0.558 |
0.769 |
| BACH1 |
O14867
|
BTB domain and CNC homolog 1
|
|
0.57 |
0.585 |
0.731 |
| IKBKB |
O14920
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
Kinase
|
0.99 |
0.506 |
0.846 |
| PER2 |
O15055
|
period circadian regulator 2
|
Transcription factor
|
0.71 |
0.488 |
0.846 |
| ANGPT2 |
O15123
|
angiopoietin 2
|
Signaling
|
0.83 |
0.410 |
0.846 |
| TLR3 |
O15455
|
toll like receptor 3
|
Receptor
|
1.6E-07 |
0.427 |
0.885 |